Market Capitalization of Eris Lifesciences (ERIS)
As of July 24, 2026, Eris Lifesciences (ERIS) market capitalisation is ₹20369.39 Cr ($2.26B), with 14.54 Cr shares outstanding at a current price of ₹1400.60 on NSE, ranking 356 out of 5363 companies by market cap in our screener. Eris Lifesciences operates in the Healthcare sector and is classified as a Large Cap stock. Compare with ERIS DCF valuation to assess whether the stock is under or overvalued.
Market Cap History of Eris Lifesciences (Last 10 Years)
ERIS market capitalisation from year-end NSE closing prices over the last 10 years. View Eris Lifesciences 52-week for the annual high/low range and current price position.
End of Year Market Cap History — Eris Lifesciences
ERIS year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. For live price, earnings and the complete company profile, see ERIS share price screener.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹20369.39 Cr
$2.26B USD
|
₹1400.60 | NSE | -6.97% |
| 2025 |
₹21896.44 Cr
$2.43B USD
|
₹1505.60 | NSE | +9.60% |
| 2024 |
₹19978.17 Cr
$2.22B USD
|
₹1373.70 | NSE | +50.96% |
| 2023 |
₹13234.43 Cr
$1.47B USD
|
₹910.00 | NSE | +40.59% |
| 2022 |
₹9413.17 Cr
$1.05B USD
|
₹647.25 | NSE | -14.84% |
| 2021 |
₹11053.66 Cr
$1.23B USD
|
₹760.05 | NSE | +31.05% |
| 2020 |
₹8434.41 Cr
$937.16M USD
|
₹579.95 | NSE | +22.35% |
| 2019 |
₹6893.54 Cr
$765.95M USD
|
₹474.00 | NSE | -31.02% |
| 2018 |
₹9993.45 Cr
$1.11B USD
|
₹687.15 | NSE | -13.50% |
| 2017 |
₹11552.50 Cr
$1.28B USD
|
₹794.35 | NSE | - |